ILMN Illumina: תחזית צמיחת רווחים לשנה הבאה

Illumina, Inc. (ILMN) maintains global priority in the NGS field, remaining resilient following its spin-off from Grail. This monopoly is sustained by a rigorous patent barrier and a closed ecosystem that prevents equipment switching. A "razor-and-blade" model ensures a steady cash flow from recurring reagent sales. The projected net profit growth rate for n+1 visualizes these expectations, where the parameter value equals 13.60.
פילוחים אנליטיים ודוחות נתונים של חברת Illumina Inc (ILMN)

Conservative capital requires high transparency of projected cash flows to ensure portfolio stability. This indicator measures analyst consensus expectations for net earnings per share growth rates in the coming year. For Illumina, Inc. (ILMN), this calculation is critical during the transition from limited scientific budgets to the high-margin oncology diagnostics market. By analyzing forward EPS dynamics, an investor determines the timing of a market trend reversal.